Newsfeeds - Spark Newswire

2 minute read

Phio Pharmaceuticals Presents New BRD4 Data At AACR-NCI-EORTC International Conference

Today, 9:48 AM

Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today

PHIO

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 9:48 AM

ACHL

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 9:48 AM

APOP

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 9:48 AM

Gainers

AWH

4 minute read

38 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 9:48 AM

Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media.

AERI

1 minute read

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

By Benzinga Insights

Today, 9:48 AM

ACER

5 minute read

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study

By Shanthi Rexaline

Today, 9:48 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15)

ACHL

2 minute read

20 Stocks Moving in Thursday’s Pre-Market Session

By Lisa Levin

Today, 9:48 AM

Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) rose 59.7% to $51.30 in pre-market trading. IronNet Cybersecurity emerged as the most-discussed stock on Reddit’s r/WallStreetBets forum as of Wednesday night.

AERI

2 minute read

Phio Pharma Highlights Data Presentation For European Society Of Medical Oncology

By Benzinga Newsdesk

Today, 9:48 AM

Local treatment with PD-1 and BRD4 dual-targeting INTASYL also showed complete resolution of tumors in vivo MARLBOROUGH, Mass., Sept. 16, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a biotechnology

PHIO